TB500 Fragment 17-24
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
TB500 (Fragment 17-23)
TB500 (Fragment 17-23)
Contact us for current batch testing data on this specification.
TB-500 (Fragment 17-23) is the N-acetylated heptapeptide Ac-LKKTETQ, corresponding to residues 17–23 of human thymosin β4, supplied as a lyophilized research peptide (CAS 885340-08-9).
Overview
TB-500 (Fragment 17-23) is a synthetic N-acetylated heptapeptide, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln. It matches residues 17–23 of mature human thymosin β4, the stretch mapped as the conserved actin-binding motif of the β-thymosin family. Material described as TB-500 has been identified by HPLC–HRMS as this acetylated fragment, with a deconvoluted mass of 888.49 Da, distinct from the 43-residue parent peptide.
What is TB-500 (Fragment 17-23)?
Human thymosin β4 is a 43-residue peptide encoded by TMSB4X (UniProt P62328). After removal of the initiator methionine, the mature chain is N-acetylated and reads Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES. Residues 17–23 of that chain are LKKTETQ. The synthetic N-acetyl derivative of this heptapeptide is the species identified in the analytical literature as TB-500. It is not full-length thymosin β4: the fragment is 7 residues and ~889 Da; the parent peptide is 43 residues and ~4.96 kDa.
Characterization
Each batch is purified by reversed-phase HPLC and confirmed by mass spectrometry. Identity is assigned to Ac-LKKTETQ when the observed monoisotopic mass matches 888.49 Da ([M+H]+ ≈ 889.50; [M+2H]2+ ≈ 445.25). Purity, identity and net peptide content are recorded on the lot-specific Certificate of Analysis.
Key Highlights
- N-acetylated heptapeptide Ac-LKKTETQ (Tβ4 residues 17–23)
- CAS 885340-08-9 · C38H68N10O14 · 889.0 g/mol
- Conserved actin-binding motif of the β-thymosin family
- ≥99% purity by HPLC; identity confirmed by mass spectrometry
- Lyophilized solid; batch COA with full traceability
Safety & Side Effects
TB-500 (Fragment 17-23) is the N-acetylated heptapeptide Ac-LKKTETQ, corresponding to residues 17–23 of human thymosin β4, supplied as a lyophilized research peptide (CAS 885340-08-9). When used in research, TB500 Fragment 17-24 should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published tb500 fragment 17-24 side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for tissue repair and recovery readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for TB500 Fragment 17-24; it is supplied strictly for laboratory research. Reported tb500 fragment 17-24 dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document tb500 fragment 17-24 dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 885340-08-9, molecular formula C38H68N10O14, molecular weight 889.0 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| Peptide | Length | Distinguishing feature |
|---|---|---|
| TB-500 (Fragment 17-23) | 7 residues, N-acetylated | Isolated actin-binding motif of thymosin β4 (Ac-LKKTETQ) |
| Thymosin β4 | 43 residues | Full-length G-actin sequestering peptide (UniProt P62328) |
| BPC-157 | 15 residues | Synthetic pentadecapeptide fragment of a gastric protein |
How to Order
Enquiry
Send sequence, specification and quantity for a quote.
Quotation
Price, lead time and specification confirmed.
QC & COA
HPLC and MS identity check; COA issued.
Delivery
Tracked worldwide shipping of the lyophilized peptide.
Specifications
| Product name | TB500 (Fragment 17-23) |
|---|---|
| Product code | TBF10 |
| Specification | 10mg*10vials |
| CAS number | 885340-08-9 |
| Molecular formula | C38H68N10O14 |
| Molecular weight | 889.0 g/mol |
| Purity | ≥99%(subject to batch COA) |
| Physical Form | Lyophilized white to off-white powder |
| Solubility | Soluble in water and aqueous buffers |
| Amino Acid Count | 7 residues (N-acetylated) |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized at −20 °C, protected from light and moisture. Bring to room temperature before opening. After reconstitution, keep refrigerated and avoid repeated freeze–thaw cycles.
Product Information Q&A
What is the amino acid sequence of TB-500 (Fragment 17-23)?
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ), the N-acetylated 17–23 region of human thymosin β4.
How does the fragment differ from full-length thymosin β4?
The fragment is a 7-residue N-acetylated peptide (~889 Da, CAS 885340-08-9). Full-length thymosin β4 is a 43-residue G-actin sequestering peptide (~4.96 kDa, CAS 77591-33-4, UniProt P62328). They are not interchangeable analytical standards.
How should TB-500 (Fragment 17-23) be stored?
Shipped as lyophilized powder. Store the dry peptide at −20 °C, protected from light and moisture.

